Anti-Adalimumab polyclonal antibody 供应商 Abnova 产品货号 PAB31791 产品报价 ￥询价/40ug 产品说明书 点击查看 购买方式 在线支付宝及网银支付、支票、现金、电汇,或拨打全国免费服务电话4006800868与我们联系。 产品新闻 背景资料 待更新 应用类型 待更新 ...
The anti-Adalimumab antibody is an anti-Idiotype antibody raised against and selected for the antigenic determinants of the variable region of Adalimumab. The antibody has been tested against a broad range of other biosimilars to ensure specificity. This highly specialized anti-idiotypic antibody can...
Human Anti-Adalimumab Antibody, clone AbD18654, is a high affinity anti-idiotypic antibody that specifically recognizes the monoclonal antibody drug adalimumab and inhibits binding to its target, TNFα. The antibody can be used to measure the levels of adalimumab and biosimilar products in bioanalyti...
Anti-Adalimumab monoclonal antibody, clone 3C2 (Biotin) 供应商 Abnova 产品货号 MAB23127 产品报价 ￥询价/40ug 产品说明书 点击查看 购买方式 在线支付宝及网银支付、支票、现金、电汇,或拨打全国免费服务电话4006800868与我们联系。 产品新闻 背景资料 ...
武汉佰乐博生物(Biolab Reagents)由五位毕业于华中科技大学,华中农业大学,武汉大学等知名高校,且具有二十年工作经验的生命科学领域顶级研究者创立于2021年,凭借丰富的产品开发经验,利用全球领先的技术平台,引进和整合全球高品质的蛋白、抗体和试剂盒产品。目前,佰乐博生物作为法国AntibodySystem和ProteoGenix在亚洲的独家总代...
Anti-Adalimumab determination kit is an in vitro diagnostic test for the quantitative detection of free anti-adalimumab antibody in human serum or plas...
Anti-Adalimumab monoclonal antibody, clone 134D5, MAB23074, highly specific and rigorously validated in-house for ELISA (ELISA), Blocking. Anti-Adalimumab monoclonal antibody, clone 134D5, MAB23074 is ready to ship.
Adalimumab (anti-TNF-α);阿达木单抗(肿瘤坏死因子-α抗体),仅用于工业应用或科学研究,不可用于人类或动物的临床诊断或治疗,非药用. Adalimumab (anti-TNF-alpha) is the first fully human, recombinant IgG1 monoclonal antibody that spec
ƙconstant regions. Adalimumab is used to treat auto-immune disorders. One of the major concerns, despite of its wide usage, is the potential development of anti drug antibody (ADA) which in turn may interfere with the drug efficacy as mainly judged by observing the relapse of signs and ...
Juvenile idiopathic arthritisAdalimumabAnti-adalimumab antibodyImmunogenicityThis study provides novel evidence of AAA production kinetics demonstrating a timely significant increase starting at 3M and stable throughout 24M. We also identified female gender, increased ESR, and leflunomide use as relevant risk ...